Cargando…

Malignant tumours of the kidney: imaging strategy

Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup,...

Descripción completa

Detalles Bibliográficos
Autores principales: Smets, Anne M., de Kraker, Jan
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861760/
https://www.ncbi.nlm.nih.gov/pubmed/20432020
http://dx.doi.org/10.1007/s00247-010-1584-z
_version_ 1782180671855263744
author Smets, Anne M.
de Kraker, Jan
author_facet Smets, Anne M.
de Kraker, Jan
author_sort Smets, Anne M.
collection PubMed
description Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup, assessment of therapy response, preoperative evaluation and follow-up. The outcome of WT after therapy is excellent with an overall survival around 90%. In tumours such as those where the outcome is extremely good, focus can be shifted to a risk-based stratification to maintain excellent outcome in children with low risk tumours while improving quality of life and decreasing toxicity and costs. This review will discuss the imaging issues for WT from the European perspective and briefly discuss the characteristics of other malignant renal tumours occurring in children and new imaging techniques with potential in this matter.
format Text
id pubmed-2861760
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-28617602010-05-10 Malignant tumours of the kidney: imaging strategy Smets, Anne M. de Kraker, Jan Pediatr Radiol Review Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms tumour (WT) or nephroblastoma is the most frequent type accounting for more than 90%. Imaging alone cannot differentiate between these tumours with certainty but it plays an important role in screening, diagnostic workup, assessment of therapy response, preoperative evaluation and follow-up. The outcome of WT after therapy is excellent with an overall survival around 90%. In tumours such as those where the outcome is extremely good, focus can be shifted to a risk-based stratification to maintain excellent outcome in children with low risk tumours while improving quality of life and decreasing toxicity and costs. This review will discuss the imaging issues for WT from the European perspective and briefly discuss the characteristics of other malignant renal tumours occurring in children and new imaging techniques with potential in this matter. Springer-Verlag 2010-04-30 2010 /pmc/articles/PMC2861760/ /pubmed/20432020 http://dx.doi.org/10.1007/s00247-010-1584-z Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Review
Smets, Anne M.
de Kraker, Jan
Malignant tumours of the kidney: imaging strategy
title Malignant tumours of the kidney: imaging strategy
title_full Malignant tumours of the kidney: imaging strategy
title_fullStr Malignant tumours of the kidney: imaging strategy
title_full_unstemmed Malignant tumours of the kidney: imaging strategy
title_short Malignant tumours of the kidney: imaging strategy
title_sort malignant tumours of the kidney: imaging strategy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861760/
https://www.ncbi.nlm.nih.gov/pubmed/20432020
http://dx.doi.org/10.1007/s00247-010-1584-z
work_keys_str_mv AT smetsannem malignanttumoursofthekidneyimagingstrategy
AT dekrakerjan malignanttumoursofthekidneyimagingstrategy